Ligand Pharmaceuticals CFO Octavio Espinoza sells $9.2m in shares
What it means
- What to watch: This one turns on a concrete figure ($9); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $LGND -0.45% in the latest session.
- Timing: It landed after the closing bell, so the session change beside it was locked in before the story existed. The next session is the first that could react.
Where the stock stands
$LGND last traded at $317.33, -0.45% on the session. That puts it 2.8% shy of its 52-week high of $326.63 and 80% clear of its low of $175.89 — within a tenth of its 52-week high. Over the year it has ranged 86% from low to high: a wide band — moves of several percent in a week come with the territory. These are latest-session quotes, not live prices — the live tape is on the $LGND page.
How much coverage it is getting
Wook has logged 2 stories on $LGND in the last 30 days, 1 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal — something has the newsroom's attention. Across those stories 0 read bullish, 2 neutral and 0 bearish. This one reads neutral, so it sits squarely with the crowd. This is the only one from Investing.com; the rest came from other outlets. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$LGND earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
The $LGND page has the full chart, the filings and the valuation model behind every figure here. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $LGND sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $LGND. It carried $9.2 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 14, 2026. $LGND has moved +8.76% ($291.77 to $317.33). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.